Neuroprotective Effects of Cannabidiol Under Cerebral Ischemic Conditions
Revista Brasileira de Farmacognosia, ISSN: 1981-528X, Vol: 31, Issue: 5, Page: 579-591
2021
- 1Citations
- 11Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Abstract: The lack of blood flow during cerebral ischemic conditions results in multiple and intricate pathophysiological mechanisms including excitotoxicity, oxidative stress, neuroinflammation, white matter injury, and blood–brain barrier impairment. Despite numerous experimental studies that have been conducted in preclinical settings, current treatments for cerebral ischemia including mechanical and pharmacological therapies are limited, and often accompanied by significant side effects. Therefore, it is necessary to investigate new strategies for treating these conditions. Cannabidiol, the most abundant non-psychotomimetic compound obtained from Cannabis sativa L., Cannabaceae, is a pleiotropic compound acting in a variety of molecular targets and may affect many pathophysiological processes resulting in improvement of cerebral ischemia outcomes. In this review, we summarize the main effects of cannabidiol in different animal models of cerebral ischemia and discuss some of its putative mechanisms of neuroprotection. Graphical Abstract: [Figure not available: see fulltext.]
Bibliographic Details
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know